“The Alzheimer’s Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launchin… Read More

On April 10, 2023, Benzinga Pro identified the top 5 stocks to watch, which are TSLA, CORT, JPM, PXD, and MODGT. Tesla has reportedly lowered its prices in the US for the fifth time this yea… Read More

In the past few years, more and more scientific studies have shown that a scary idea is true: Alzheimer’s disease is an infection, not a disease. Experts are still trying to figure out… Read More

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company developing therapeutic approaches to improve the lives of… Read More

New York, New York--(Newsfile Corp. - April 21, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Cortexyme, Inc. ("Affirm" or the "Company") (NASDAQ: CRTX). Such inv… Read More

Slate of Accomplished Leaders Poised to Accelerate Growth of AI-Driven Precision Medicine Startup Zephyr AI, Inc. (“Zephyr AI”), a high-growth healthcare technology company co… Read More

This article Cortexyme publishes data on P. gingivalis ability to infect neurons appeared first on Project Topics. Drive Alzheimer’s-like pathology in the Journal of Alzheimer’s… Read More

The Hourly View for Pfizer At the time of this writing, PFE’s price is up $0.13 (0.27%) from the hour prior. This is a reversal of the price action on the previous hour, in which price… Read More

Short-sellers are back for revenge after getting crushed during 2020 and the better part of last year. New research from Axios shows consumer discretionary are the most shorted stocks i… Read More

Deep science investor Lindy Fishburne cofounded the seed- and early-stage venture firm Breakout Ventures several years ago, after cofounding Breakout Labs within the Thiel Foundation back in… Read More

WeWork is grabbing all the headlines for its failed attempt to continue the illusion that it’s worth tens of billions of dollars. As it tried to make the transition from a private comp… Read More

Rund 25% der neuen Pfizer Ventures Mittel werden für den Bereich Neurowissenschaften bereitgestellt Durch die Ausweitung der Venture-Capital-Investitionen unter Pfizer Ve… Read More